Investigation launched into Immunovant officers for possible self-dealing harming shareholders

Kuehn Law, PLLC is investigating whether certain officers and directors of Immunovant, Inc. breached their fiduciary duties through potential self-dealing. This probe could lead to shareholder damages and demands for corporate governance reforms. Long-term Immunovant shareholders are encouraged to contact the law firm for a free consultation to protect their rights. The case highlights concerns about management accountability and shareholder protection in the company.

Immunovant Inc. shares are currently priced at USD 29.56 on Pluang, down 2.99% in the last day. The stock has a market cap of $6.29 billion and a typical hold time of 4 days. These figures are as of Oct 13, 2026 06:21 WIB.